Clinirem Sp. z o.o.

Lublin 26 trials 12 recruiting

26 Registered trials

12 Currently recruiting

Organisation

Clinirem Sp. z o.o.

Location

Lublin, Poland

Identifier

ORG-100044226

Address

Wielicka 42 Lokal U 3, 02-657, Poland

Departments

-
Galen Clinic
N/A
NA
Neurology

Clinical trials at this site (26)

Search interface

A Phase 3 Study of Orelabrutinib in Non-active Secondary Progressive Multiple Sclerosis Pending

2025-524322-18-00 Non-active Secondary Progressive Multiple Sclerosis (SP 5
A Phase 3 Study of Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis Recruiting

2025-524316-11-00 Primary Progressive Multiple Sclerosis (PPMS) 5 2026-06-11
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis Recruiting

2024-512126-29-00 Generalized Myasthenia Gravis 5 2025-02-25
A Phase 2 study of DNTH103 in patients with Generalized Myasthenia Gravis Recruiting

2024-512865-15-00 Generalized Myasthenia Gravis 4 2024-09-03
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis Recruiting

2023-507539-40-00 Myasthenia Gravis 4 2024-07-19
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in… Recruiting

2025-525127-27-00 Generalized Myasthenia Gravis 9 2026-06-08
A Phase 2b Study of IMVT-1402 Treatment in CIDP Recruiting

2024-517614-14-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2025-11-28
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) Recruiting

2024-517529-26-00 Chronic Inflammatory Demyelinating Polyneuropathy 5 2025-08-04
A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Dem… Recruiting

2024-517450-95-00 Chronic inflammatory demyelinating polyradiculoneuropat 5 2025-06-23
Efficacy and Safety Study of Nipocalimab for Adults with CIDP Recruiting

2023-508425-28-00 Chronic Inflammatory Demyelinating Polyneuropathy 4 2022-10-24
Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis Recruiting

2023-504152-97-00 Generalized Myasthenia Gravis 5 2021-11-26
A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with chronic inflammatory demyel… Recruiting

2023-507885-21-00 Chronic Inflammatory Demyelinating Polyneuropathy 4 2020-08-18
A study to assess the efficacy and safety of Empasiprubart versus IVIg in adults with Multifocal Motor Neuropathy Ended

2024-516473-72-00 Multifocal Motor Neuropathy 5 2025-07-31
A study to assess efficacy and safety of efgartigimod PH20 SC in adults with ocular myasthenia gravis Ended

2024-514133-38-00 Ocular Myasthenia Gravis 5 2025-03-19
A Phase 3 study to evaluate the Efficacy and Safety of Efgartigimod IV in Patients with Acetylcholine Receptor Binding Antibody Seronegative… Ended

2024-511796-15-00 Acetylcholine Receptor Binding Antibody Seronegative Ge 5 2024-10-16
An international randomized clinical study, measuring safety and effectiveness of basimglurant for the treatment of pain in patients with Tr… Ended

2024-514497-41-00 Trigeminal neuralgia 10 2022-03-24
An extension study to learn if Zilucoplan is safe and works over a long period in adult participants with generalized myasthenia gravis. Ended

2024-512399-37-00 Generalized Myasthenia Gravis 5 2020-12-29
Safety, Tolerability, and Efficacy of NVG-2089 in Participants with CIDP Ended

2024-515386-34-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2025-05-29
A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP Ended

2024-518364-12-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2025-05-09
A dose-finding trial with LU AG90222 in adults with migraine who have not been helped by prior preventative treatments. Ended

2023-508821-28-00 Migraine 4 2024-08-14
C4951004 - BHV3000-406: A Phase 4, Randomized, Double-blind Placebo Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute … Ended

2024-513269-37-00 Migraine attacks with or without aura 6 2023-03-14
C4951012 - BHV3000-407: A Phase 4, Randomized, Double-blind, Placebo controlled Study to Evaluate the Efficacy and Tolerability of Rimegepan… Ended

2024-513270-21-00 migraine headaches with or without aura 6 2023-03-14
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Prospective, 52-Week, Phase 2 Clinical Study to Evaluate the S… Ended

2024-511610-20-00 Alzheimer's Disease 4 2022-11-08
An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasth… Ended

2024-510932-36-00 Generalized Myasthenia Gravis (gMG) 5 2021-12-21